AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Jan 4, 2018
30071_dirs_2018-01-04_5a836508-5c44-4d0c-9869-a6c67928b858.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-01-02
Reporting Person: Hollingshead James (President, Sleep Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-02 | ResMed Common Stock | S | 600 | $84.96 | Disposed | 62602 | Direct |
Footnotes
F1: The transaction was conducted under a Rule10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $84.93 to $84.98. The price reported above reflects the weighted average sale price.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29